Sharon K Tomberlin, MD | |
1202 S Tyler St, Covington, LA 70433-2330 | |
(985) 898-4417 | |
Not Available |
Full Name | Sharon K Tomberlin |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 45 Years |
Location | 1202 S Tyler St, Covington, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003808700 | NPI | - | NPPES |
1364266 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | L015225 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ochsner Clinic Foundation | New orleans, LA | Hospital |
Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ochsner Clinic Llc | 8224933619 | 2403 |
Ochsner Mississippi, Llc | 0143580993 | 113 |
News Archive
Women with migraines did not appear to experience a decline in cognitive ability over time compared to those who didn't have them, according to a nine-year follow up study funded by the National Institutes of Health.
Pediatricians are not referring more than half of the children who fail hearing screenings for further tests, according to new research by a Saint Louis University physician. The study was published in the October issue of the Archives of Pediatrics and Adolescent Medicine.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.
› Verified 9 days ago
Entity Name | Ochsner Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Women with migraines did not appear to experience a decline in cognitive ability over time compared to those who didn't have them, according to a nine-year follow up study funded by the National Institutes of Health.
Pediatricians are not referring more than half of the children who fail hearing screenings for further tests, according to new research by a Saint Louis University physician. The study was published in the October issue of the Archives of Pediatrics and Adolescent Medicine.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Sharon K Tomberlin, MD Po Box 15239, Baton Rouge, LA 70895-5239 Ph: (800) 287-7462 | Sharon K Tomberlin, MD 1202 S Tyler St, Covington, LA 70433-2330 Ph: (985) 898-4417 |
News Archive
Women with migraines did not appear to experience a decline in cognitive ability over time compared to those who didn't have them, according to a nine-year follow up study funded by the National Institutes of Health.
Pediatricians are not referring more than half of the children who fail hearing screenings for further tests, according to new research by a Saint Louis University physician. The study was published in the October issue of the Archives of Pediatrics and Adolescent Medicine.
Drugs produced using biotechnology are among the most expensive medicines available. Biosimilars that offer a real alternative are becoming increasingly available on the market.
MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.
› Verified 9 days ago
Pamela M Bartholomew, M D Pathology Medicare: Accepting Medicare Assignments Practice Location: 67241 Industry Ln, Covington, LA 70433 Phone: 985-892-7206 Fax: 985-892-9990 | |
Dr. Kim Sutker Kaye, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 95 Judge Tanner Blvd, Covington, LA 70433 Phone: 985-867-4046 | |
Dr. Gloria Battle Coker, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 71250 Hendry Ave, Covington, LA 70433 Phone: 985-892-7130 Fax: 985-893-0590 | |
Dr. Jordan Andrew Roberts, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 95 Judge Tanner Blvd, Covington, LA 70433 Phone: 985-867-4046 | |
Dr. Jeffrey H Loose, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1202 S Tyler St, Covington, LA 70433 Phone: 985-898-4097 Fax: 985-871-5755 |